scholarly article | Q13442814 |
P356 | DOI | 10.1097/00000542-198503000-00017 |
P50 | author | David J. Greenblatt | Q88911712 |
P2093 | author name string | J. G. Reves | |
H. Ronald Vinik | |||
Robert J. Fragen | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 310-324 | |
P577 | publication date | 1985-03-01 | |
P1433 | published in | Anesthesiology | Q2012635 |
P1476 | title | Midazolam | |
P478 | volume | 62 |
Q41952889 | A Distress Protocol for Respiratory Emergencies in Terminally Ill Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease |
Q47370127 | A Protocol for the Control of Agitation in Palliative Care |
Q39175922 | A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications |
Q46835635 | A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures |
Q33785079 | A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma. |
Q38714565 | A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects |
Q42280571 | A prospective study of the adverse effects of midazolam on withdrawal in critically ill children |
Q51126818 | A randomized, controlled trial of oral midazolam and buffered lidocaine for suturing lacerations in children (the SLIC Trial). |
Q89333663 | A soft benzodiazepine |
Q35804041 | Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers |
Q38154852 | Alternative delivery systems for agents to treat acute agitation: progress to date |
Q47339027 | An ultra-sensitive LC-MS/MS method to determine midazolam levels in human plasma: development, validation and application to a clinical study |
Q51605392 | Analgesia and sedation in interventional radiological procedures |
Q51752814 | Anesthesia for outpatient dermatologic cosmetic surgery: midazolam--low-dosage ketamine anesthesia. |
Q48109823 | Antagonistic effect of flumazenil after midazolam sedation on arterial-cardiac baroreflex |
Q41882963 | Attenuation of reperfusion hyperalgesia in the rat by systemic administration of benzodiazepines |
Q43508896 | Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry. |
Q34474026 | Benzodiazepines in the intensive care unit |
Q51473449 | Buccal route for benzodiazepines in treatment of seizures? |
Q51669156 | Cardiorespiratory effects of combined midazolam and butorphanol in isoflurane-anesthetized cats. |
Q35675079 | Clinical approach to the critically ill, morbidly obese patient |
Q27006333 | Clinical pharmacology of midazolam in neonates and children: effect of disease-a review |
Q51567584 | Cobra bite victim: down but not out. |
Q51743818 | Combination of midazolam and flumazenil in upper gastrointestinal endoscopy, a doubleblind randomized study. |
Q47740766 | Comparative study of hemodynamic changes caused by diazepam and midazolam during third molar surgery: a randomized controlled trial. |
Q59123214 | Comparing the Analgesic Efficacy of Intrathecal Bupivacaine Alone with Intrathecal Bupivacaine Midazolam or Magnesium Sulphate Combination in Patients Undergoing Elective Infraumbilical Surgery |
Q39553249 | Comparison of intravenous midazolam with pentobarbital for sedation for head computed tomography imaging |
Q45003978 | Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus |
Q38058131 | Conscious sedation and anesthesia in the cardiac electrophysiology laboratory |
Q51471674 | Continuous infusion versus bolus administration of sufentanil and midazolam for mitral valve surgery. |
Q43958368 | Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus |
Q42633141 | Delayed Onset and Prolonged ECT-Related Delirium |
Q43825910 | Determination of midazolam in human plasma by solid-phase microextraction and gas chromatography/mass spectrometry |
Q51565240 | Determination of the steady state tissue distribution of midazolam in the rat. |
Q39094487 | Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal. |
Q51679698 | Diazepam versus midazolam for colonoscopy: a prospective evaluation of predicted versus actual dosing requirements |
Q51540316 | Does Midazolam Cause Retrograde Amnesia, and Can Flumazenil Reverse That Amnesia? |
Q94661979 | Dose and cardiopulmonary effects of propofol alone or with midazolam for induction of anesthesia in critically ill dogs |
Q51792052 | Dose-finding and pharmacokinetic study of intramuscular midazolam. |
Q39426209 | EVALUATION OF MIDAZOLAM AND DIAZEPAM FOR PRE-OPERATIVE SEDATION. |
Q51373503 | Effect of conscious sedation on cardiac autonomic regulation during colonoscopy. |
Q42079518 | Effect of flumazenil on disturbance of equilibrium function induced by midazolam |
Q44073680 | Effect of pre-operative anxiolysis on postoperative pain response in patients undergoing total abdominal hysterectomy. |
Q46614118 | Effect of sedation with midazolam or propofol on patient's comfort during cancer chemotherapy infusion: a prospective, randomized, double-blind study in breast cancer patients |
Q91585715 | Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers |
Q45162030 | Effects of intravenous midazolam and diazepam on patient response, percentage of oxygen saturation, and hemodynamic factors during periodontal surgery |
Q42062910 | Efficacy of rectal midazolam for the sedation of preschool children undergoing laceration repair |
Q47253558 | Evaluation of the use of midazolam as a co-induction agent with ketamine for anaesthesia in sedated ponies undergoing field castration. |
Q49087692 | Evaluation of three midazolam-xylazine mixtures. Preliminary trials in dogs |
Q41830830 | Evidence of CYP3A allosterism in vivo: analysis of interaction between fluconazole and midazolam |
Q40421258 | Feasibility of deep sedation with a combination of propofol and dexmedetomidine hydrochloride for esophageal endoscopic submucosal dissection |
Q53709697 | Flumazenil and peroperative awakening in surgery of scoliosis |
Q50112615 | Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy |
Q44066014 | Hemodynamic effects of intravenous midazolam-xylazine-butorphanol in dogs |
Q35837717 | High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment. |
Q51699202 | Holter ECG monitoring of sympathovagal fluctuation during bronchoscopy. |
Q45279289 | Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism |
Q51540327 | Interaction of Midazolam with the Nicotinic Acetylcholine Receptor of Mouse Myotubes |
Q46838446 | Intranasal midazolam in patients with status epilepticus |
Q43493233 | Intravenous infusion anesthesia with Propofol-Midazolam-fentanyl for experimental surgery in swine |
Q41169799 | Intubation of critically ill patients |
Q34357736 | Is cyclosporin A an inhibitor of drug metabolism? |
Q44897899 | Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions. |
Q38700666 | Lytic/"DPT" cocktail: time for rational and safe alternatives |
Q51372283 | Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level. |
Q51686207 | Methohexital in the ED |
Q33635683 | Midazolam and pentobarbital for refractory status epilepticus |
Q51688226 | Midazolam for outpatient sedation |
Q51721394 | Midazolam for sedation in the paediatric intensive care unit |
Q51633719 | Midazolam for treatment of refractory neonatal seizures. A case report. |
Q51562990 | Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents. |
Q58992148 | Midazolam in Subarachnoid Block: Current Evidence |
Q37462699 | Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice. |
Q35802566 | Midazolam pharmacokinetics following intravenous and buccal administration |
Q41564307 | Midazolam: a review of therapeutic uses and toxicity |
Q90574143 | Minimum anesthetic concentration of isoflurane and sparing effect of midazolam in Quaker parrots (Myiopsitta monachus) |
Q57004702 | Modeling the effects of commonly used drugs on human metabolism |
Q51102183 | Multidrug intravenous sedation: determinants of the sedative dose of midazolam. |
Q44831778 | Neurophysiologic and long-term effects of clinical hypnosis in oral and maxillofacial treatment--a comparative interdisciplinary clinical study |
Q39488441 | New perspectives on anesthetic agents |
Q28484896 | Nociceptive transmission to rat primary somatosensory cortex--comparison of sedative and analgesic effects |
Q41563152 | Opioid and benzodiazepine tolerance and dependence: application of theory to critical care practice |
Q40931858 | Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. |
Q46136784 | Optimising the dose of oral midazolam sedation for dental procedures in children: a prospective, randomised, and controlled study |
Q37423847 | Oral midazolam premedication for children undergoing general anaesthesia for dental care |
Q41324757 | Oral midazolam sedation in third molar surgery |
Q51535216 | Oral transmucosal fentanyl citrate as an additional premedicant for adult cardiac surgery patients. |
Q38019029 | Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures |
Q51673939 | Patient awareness under general anesthesia. |
Q30961511 | Pediatric endoscopy: Anesthesia and surgical techniques |
Q44138114 | Percutaneous balloon kyphoplasty with the patient under intravenous analgesia and sedation: a feasibility study |
Q24613149 | Pharmacodynamic considerations for moderate and deep sedation |
Q38809021 | Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. |
Q44937269 | Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman |
Q41775186 | Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration |
Q39979640 | Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer |
Q40815584 | Pharmacokinetics and pharmacodynamics in the critically ill patient |
Q51771688 | Pharmacokinetics and pharmacodynamics of midazolam in the enflurane-anesthetized dog. |
Q51678019 | Pharmacokinetics and preliminary observations of behavioral changes following administration of midazolam to dogs. |
Q41966138 | Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration |
Q43501441 | Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration |
Q39361432 | Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers. |
Q41153797 | Pharmacologic Studies of the Neuroprotective Actions of a Glutamate Antagonist in Ischemia |
Q36923576 | Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil |
Q39481046 | Pharmacology of intravenous sedatives and opioids in critically ill patients. |
Q58295000 | Photometric Flow Injection Determination of Psychotropic Drugs: Brotizolam and Midazolam |
Q51096183 | Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy. |
Q51625090 | Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. |
Q47666436 | Polymorphism rs4263535 in GABRA1 intron 4 was related to deeper sedation by intravenous midazolam |
Q51723522 | Postoperative analgesic requirements following flumazenil administration. |
Q38995371 | Practical Management of Anaesthesia in the Elderly |
Q98906701 | Prediction of cardiopulmonary events using the STOP-Bang questionnaire in patients undergoing bronchoscopy with moderate sedation |
Q45242628 | Predictive factors of oxygen desaturation of patients submitted to endoscopic retrograde cholangiopancreatography under conscious sedation |
Q48301824 | Preemptive analgesia with midazolam and diclofenac for hernia repair pain |
Q51526035 | Propofol and fentanyl compared with midazolam and fentanyl during third molar surgery. |
Q51161014 | Propofol for sedation during endoscopy: assessment of a computer-controlled infusion system. |
Q51111195 | Propofol versus midazolam for sedation during percutaneous transluminal angioplasty. |
Q45941949 | Pulmonary hypertension in first episode infective endocarditis among intravenous buprenorphine users: case report. |
Q36290220 | Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor |
Q44155196 | RETRACTED: Flumazenil Recovers Diaphragm Muscle Dysfunction Caused by Midazolam in Dogs |
Q43748308 | RETRACTED: Midazolam versus propofol for reducing contractility of fatigued canine diaphragm |
Q44559123 | RETRACTED: Midazolam-induced muscle dysfunction and its recovery in fatigued diaphragm in dogs |
Q51528473 | Randomized, double-blind study on sedatives and hemodynamics during rapid-sequence intubation in the emergency department: The SHRED Study. |
Q68049010 | Rapid and sensitive high-performance liquid chromatographic assay for midazolam and 1-hydroxymidazolam, the major metabolite, in human serum |
Q51703594 | Recovery after total intravenous anaesthesia using combined midazolam/alfentanil infusion and reversal with flumazenil |
Q51428957 | Rectal sedation with diazepam or midazolam during extractions of traumatized primary incisors: a prospective, randomized, double-blind trial in Swedish children aged 1.5-3.5 years. |
Q43851063 | Reoxygenation after cold hypoxic storage of cultured precision-cut rat liver slices: effects on cellular metabolism and drug biotransformation |
Q28546872 | Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations |
Q42097865 | Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam |
Q40964080 | Resuscitation of the geriatric patient |
Q51664712 | Risk factors associated with vasovagal reactions during colonoscopy. |
Q44094199 | Role of temperature on protein and mRNA cytochrome P450 3A (CYP3A) isozymes expression and midazolam oxidation by cultured rat precision-cut liver slices |
Q36336064 | Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models |
Q73840166 | Sedation and analgesia for oncological patients undergoing interventional radiologic procedures |
Q37918945 | Sedation and anesthesia for CT: emerging issues for providing high-quality care. |
Q38040844 | Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm |
Q42194086 | Sedation for upper gastrointestinal endoscopy: a comparative study of midazolam and diazepam |
Q43968345 | Sedation with intranasal midazolam for endoscopy of the upper digestive tract |
Q51101560 | Sedation with intravenous midazolam in the pediatric intensive care unit. |
Q38955743 | Sedation with orally administered midazolam in elderly dental patients with major neurocognitive disorder |
Q51382255 | Sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study. |
Q48509060 | Sleep-related nocturnal erections and erections during midazolam-induced sedation in healthy young men. |
Q46582164 | Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin |
Q51582724 | Steady-state plasma concentrations of midazolam in critically ill infants and children. |
Q51488557 | Sublingual midazolam premedication in children: a dose response study. |
Q34060484 | Telazol--a review of its pharmacology and use in veterinary medicine. |
Q38643532 | The Emergence of Second-Generation Lethal Injection Protocols: A Brief History and Review |
Q51595732 | The Influence of High Spinal Anesthesia on Sensitivity to Midazolam Sedation |
Q46186946 | The behaviour of healthy awake cats following intravenous and intramuscular administration of midazolam |
Q43996931 | The combined effects of midazolam and propofol sedation on muscle power |
Q44039671 | The effect of intravenous administration of variable-dose flumazenil after fixed-dose ketamine and midazolam in healthy cats |
Q45978855 | The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats. |
Q33698566 | The effectiveness of midazolam as a single pharmacologic agent to facilitate endotracheal intubation by paramedics |
Q51538294 | The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam. |
Q48153474 | The effects of intravenous anesthetics on mouse embryonic fibroblast viability and proliferation |
Q51549348 | The effects of midazolam and flumazenil on psychomotor function. |
Q31891589 | The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients |
Q46191616 | The optimal intravenous dose of midazolam after intravenous ketamine in healthy awake cats |
Q37857544 | The pharmacology of airway management in critical care |
Q38218631 | The safety and tolerability of intranasal midazolam in epilepsy |
Q51423108 | The utilization of midazolam as a pharmacologic adjunct to endotracheal intubation by paramedics. |
Q45043252 | Thiamylal- and halothane-sparing effect of diazepam in dogs |
Q37200571 | Transdermal lovastatin enhances fracture repair in rats |
Q44117375 | UK National Clinical Guidelines in Paediatric Dentistry. Managing anxious children: the use of conscious sedation in paediatric dentistry |
Q48307501 | Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report |
Q33589560 | Use of intramuscular midazolam for status epilepticus |
Q45115606 | Use of midazolam for refractory status epilepticus in pediatric patients |
Q51479446 | Use of midazolam in the treatment of refractory status epilepticus. |
Q37733572 | Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity? |
Q42558120 | Venous complications of midazolam versus diazepam |
Q81565636 | [Clinical practice guideline based on the evidence for the management of sedoanalgesia in the critically ill adult patient] |
Q69818343 | [Pharmacology of midazolam] |
Q72889158 | [Respiratory effects of midazolam in patients with obstructive sleep apnea syndromes] |
Q51566503 | [The effects of midazolam on oxygen consumption and the level of vigilance. The possibility of the sedative effect of the plexiglas dome (canopy) of the Deltatrac indirect calorimetry device] |
Q53711249 | [Use of flumazenil (RO 15-1788) after prolonged infusion of midazolam in anesthesia for intracranial surgery] |
Search more.